dc.contributor.author |
Ramharter, Michael |
de_DE |
dc.date.accessioned |
2014-03-04T08:59:34Z |
|
dc.date.available |
2014-03-04T08:59:34Z |
|
dc.date.issued |
2012 |
de_DE |
dc.identifier.issn |
0264-410X |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/42805 |
|
dc.language.iso |
en |
en |
dc.publisher |
Elsevier Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.vaccine.2012.09.005 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140226071329_00412 |
de_DE |
utue.publikation.seiten |
6864-6870 |
de_DE |
utue.personen.roh |
Lagler, Heimo |
de_DE |
utue.personen.roh |
Tobudic, Selma |
de_DE |
utue.personen.roh |
Ramharter, Michael |
de_DE |
utue.personen.roh |
Elandt, Katarzyna |
de_DE |
utue.personen.roh |
Sperr, Wolfgang R. |
de_DE |
utue.personen.roh |
Redlberger-Fritz, Monika |
de_DE |
utue.personen.roh |
Popow-Kraupp, Theresia |
de_DE |
utue.personen.roh |
Jaeger, Ulrich |
de_DE |
utue.personen.roh |
Zielinski, Christoph C. |
de_DE |
utue.personen.roh |
Burgmann, Heinz |
de_DE |
dcterms.isPartOf.ZSTitelID |
Vaccine |
de_DE |
dcterms.isPartOf.ZS-Issue |
48 |
de_DE |
dcterms.isPartOf.ZS-Volume |
30 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |